Welcome
Support Centre
02 September 2010 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
A randomised prospective controlled study to assess the effects of a respiratory case management model on hospital readmission rates in patients with moderate to severe chronic obstructive pulmonary disease
ISRCTN ISRCTN33946398
ClinicalTrials.gov identifier
Public title A randomised prospective controlled study to assess the effects of a respiratory case management model on hospital readmission rates in patients with moderate to severe chronic obstructive pulmonary disease
Scientific title
Acronym EXHALE (Exercise, Home support and Lung Education)
Serial number at source N/A
Study hypothesis Whether intensive education, support and individualised exercise programme can reduce hospital admissions in patients with moderate to severe Chronic Obstructive Pumonary Disease (COPD).
Ethics approval Added 18/03/10:
Sefton Research and Ethics Committee. Ref: 04/Q1501/75, September 2004.
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Chronic Obstructive Pulmonary Disease
Participants - inclusion criteria 1. Patients with moderate to severe COPD confirmed on spirometry
2. Aged 40 years or more who have had one or more admission to hospital in last 12 months
3. Must be current or ex-smokers
4. Must have home telephone
Participants - exclusion criteria 1. Patients with previous diagnosis of asthma
2. Significant/unstable cardiac dysfunction
3. Underlying malignancy, dementia or major psychiatric illness
4. Participation in pulmonary rehabillitation in last 12 months
Anticipated start date 01/10/2004
Anticipated end date 30/09/2006
Status of trial Completed
Patient information material Not available in web format, please use the contact details below to request a patient information sheet
Target number of participants 270
Interventions Case management model of care: weekly home visits and small group exercise sessions for eight weeks. Monthly visits thereafter, with weekly, then fortnightly phone calls. Dedicated telephone support seven days a week for 12 months.

Control group have usual care.
Primary outcome measure(s) Number of hospital admissions for COPD at 12 months.
Secondary outcome measure(s) 1. Quality of life/health status
2. Exercise capacity, lung function, and treatment over a one year period
3. Total number and length of hospital admissions for any cause
4. Number of General Practitioner visits, accident and emergency department visits over the 12 month follow up
Sources of funding South Sefton Primary Care Trust (in collaboration with Liverpool and Knowsley Primary Care Trusts) (UK)
Trial website
Publications
Contact name Dr  Lisa  Davies
  Address Aintree Chest Centre
University Hospital Aintree
Lower Lane
  City/town Liverpool
  Zip/Postcode L9 7AL
  Country United Kingdom
  Tel +44 (0)151 529 3796
  Fax +44 (0)151 529 2873
  Email lisa.davies@aintree.nhs.uk
Sponsor University Hospital Aintree (UK)
  Address Lower Lane
  City/town Liverpool
  Zip/Postcode L9 7AL
  Country United Kingdom
  Tel +44 (0)151 529 3796
  Fax +44 (0)151 529 2873
  Email lisa.davies@aintree.nhs.uk
Date applied 13/09/2005
Last edited 18/03/2010
Date ISRCTN assigned 27/09/2006
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2010 ISRCTN unless otherwise stated.


BioMed Central